Monitoring singlet oxygen in situ with delayed chemiluminescence to deduce the effect of photodynamic therapy

Journal of Biomedical Optics

Volumn 13, Issue 2, 2008, Pages

  Wei, Yanchun ^a   Xing, Da ^a   Luo, Shiming ^a   Xu, Wei ^a   Chen, Qun ^a,b  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

chemiluminescence; photodynamic therapy; singlet oxygen; skin

Indexed keywords

CELL KILLING; EXCITATION LIGHT; IN-SITU; IN-VITRO; IN-VIVO; IN-VIVO MEASUREMENT; SINGLET OXYGEN;

CHEMILUMINESCENCE; MAMMALS; OXYGEN; PLASMONS; SIGNAL DETECTION;

PHOTODYNAMIC THERAPY;

SINGLET OXYGEN;

ARTICLE; CHEMOLUMINESCENCE; EQUIPMENT; EQUIPMENT DESIGN; INSTRUMENTATION; METHODOLOGY; PHOTOCHEMOTHERAPY; SENSITIVITY AND SPECIFICITY;

CHEMILUMINESCENT MEASUREMENTS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; PHOTOCHEMOTHERAPY; SENSITIVITY AND SPECIFICITY; SINGLET OXYGEN;

EID: 49649103236     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.2904961     Document Type: Article

References (40)

1. H., Kostron, A., Obwegeser, and R., Jakober, " Photodynamic therapy in neurosurgery: a review, ", J. Photochem. Photobiol., B, 36, 157-168 (1996). jpw JPPBEG 1011-1344 10.1016/S1011-1344(96)07364-2
2. N. L., Oleinick, R. L., Morris, and I., Belichenko, " The role of apoptosis in response to photodynamic therapy: what, where, why, and how, ", Photochem. Photobiol. Sci., 1 (1), 1-21 (2002). bk8 PPSHCB 1474-905X 10.1039/b108586g
3. S. B., Brown, E. A., Brown, and I., Walker, " The present and future role of photodynamic therapy in cancer treatment, ", Lancet Oncol., 5, 497-508 (2004).
4. C. S., Foote, " Definition of type I and type II photosensitized oxidation, ", Photochem. Photobiol., 54, 659-661 (1991). pho PHCBAP 0031-8655 10.1111/j.1751-1097.1991.tb02071.x
5. J., Moan, Q., Peng, R., Sorensen, V., Iani, and J. M., Nesland, " The biophysical foundations of photodynamic therapy, ", Endoscopy, 30, 387-391 (1998). 4jf ZZZZZZ 0013-726X
6. J., Yamamoto, S., Yamamoto, T., Hirano, S. Y., Li, M., Koide, E., Kohno, M., Okada, C., Inenaga, T., Tokuyama, N., Yokota, S., Terakawa, and H., Namba, " Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma, ", Clin. Cancer Res., 12 (23), 7132-7139 (2006). 84q ZZZZZZ 1078-0432
7. D., Nowis, M., Makowski, T., Stokosa, M., Legat, T., Issat, and J., Golab " Direct tumor damage mechanisms of photodynamic therapy, ", Acta Biochim. Pol., 52 (2) 339-352 (2005). 22j ABPLAF 0001-527X
8. G. M., Griffin, T., Zhu, M., Solonenko, F. D., Piero, A., Kapakin, T. M., Busch, A., Yodh, G., Polin, T., Bauer, D., Fraker, and S. M., Hahn, " Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model, ", Clin. Cancer Res., 7 (2), 374-381 (2001). 84q ZZZZZZ 1078-0432
9. I. A., Boere, D. J., Robinson, H. S., de Bruijn, J., van den Boogert, H. W., Tilanus, H. J., Sterenborg, and R. W., de Bruin, " Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy, ", Photochem. Photobiol., 78 (3), 271-278 (2003). pho PHCBAP 0031-8655 10.1562/0031-8655(2003) 078<0271:MISDAP>2.0.CO;2
10. L., Lilge, N., Pomerleau-Dalcourt, A., Douplik, S. H., Selman, R. W., Keck, M., Szkudlarek, M., Pestka, and J., Jankun, " Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2- mediated PDT, ", Phys. Med. Biol., 49, 3209-3225 (2004). pme PHMBA7 0031-9155 10.1088/0031-9155/49/14/014
11. M. C. G., Aalders, M. L., Triesscheijn, and M., Ruevekamp, " Doppler optical coherence tomography to monitor the effect of photodynamic therapy on tissue morphology and perfusion, ", J. Biomed. Opt., 11, 044011 (2006). jbo JBOPFO 1083-3668 10.1117/1.2337302
12. B. W., Henderson, S. O., Gollnick, J. W., Snyder, T. M., Busch, P. C., Kousis, R. T., Cheney, and J., Morgan, " Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors, ", Cancer Res., 64 (15), 2120-2126 (2004). cnr CNREA8 0008-5472 10.1158/0008-5472.CAN-03-3513
13. S. K., Bisland, J. W., Austin, D. P., Hubert, and L., Lilge, " Photodynamic actinometry using microspheres: concept, development and responsivity, ", Photochem. Photobiol., 79 (4), 371-379 (2004). pho PHCBAP 0031-8655 10.1562/FR-03-18.1
14. S. B., ZHou, ZH. H., Zhang, Q., Liu, S. H. Q., Zeng, and Q. M., Luo, " The application of optical imaging: studying the photodynamic effect of tumor in vivo, ", Prog. Biochem. Biophys., 32 (10), 969-974 (2005).
15. B. C., Wilson, M. S., Patterson, and L., Lilge, " Implicit and explicit dosimetry in photodynamic therapy: a new paradigm, ", Lasers Med. Sci., 12, 182-199 (1997). cfo ZZZZZZ 0268-8921
16. M. J., Niedre, M. S., Patterson, and B. C., Wilson, " Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo, ", Photochem. Photobiol., 75, 382-391 (2002). pho PHCBAP 0031-8655 10.1562/0031-8655(2002)075<0382: DNILDO>2.0.CO;2
17. M. T., Jarvi, M. J., Niedre, M. S., Patterson, and B. C., Wilson, " Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects, ", Photochem. Photobiol., 82, 1198-1210 (2006). pho PHCBAP 0031-8655 10.1562/2006-05-03-IR-891
18. ′ -[2-(9-anthryloxy)ethylthio] tetrathiafulvalene, a highly selective and sensitive chemiluminescence probe for singlet oxygen, ", J. Am. Chem. Soc., 126, 11543-11548 (2004). acs JACSAT 0002-7863 10.1021/ja0481530
19. K., Teranishi and T., Nishiguchi, " Cyclodextrin-bound 6-(4-methoxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-ones with fluorescein as green chemiluminescent probes for superoxide anions, ", Anal. Biochem., 325, 185-195 (2004). ana ANBCA2 0003-2697 10.1016/j.ab.2003.10.042
20. 2 -dependent generation of singlet oxygen from human saliva with a novel chemiluminescence probe, ", Biochim. Biophys. Acta, 1760, 440-444 (2006). bba BBACAQ 0006-3002
21. Y. C., Wei, J., Zhou, D., Xing, and Q., Chen, " In vivo monitoring of singlet oxygen using delayed chemiluminescence during photodynamic therapy, ", J. Biomed. Opt., 12 (1), 014002 (2007). jbo JBOPFO 1083-3668 10.1117/1.2437151
22. M., Hao, D., Xing, Q., Chen, and J., Wang, " A high sensitivity detection method of singlet oxygen and superoxide anion, ", Chin. Chem. Lett., 15 (6), 679-682 (2004). c33 CCLEE7 1001-8417
23. J., Wang, D., Xing, Y. H., He, and X. J., Hu, " Experimental study on photodynamic diagnosis of cancer mediated by chemiluminescence probe, ", FEBS Lett., 523, 128-132 (2002). feb FEBLAL 0014-5793 10.1016/S0014-5793(02) 02961-7
24. Y. F., Qin, D., Xing, J., Zhou, S. M., Luo, and Q., Chen, " Feasibility of using fluoresceinyl cypridina luciferin analog in a novel chemiluminescence method for real-time photodynamic therapy dosimetry, ", Photochem. Photobiol., 81 (6), 1534-1538 (2005). pho PHCBAP 0031-8655 10.1562/2005-05-20-RA-536
25. Y. h., He, D., Xing, S. C., Tan, Y. H., Tang, and K. I., Ueda, " In vivo sonoluminescence imaging with the assistance of FCLA, ", Phys. Med. Biol., 47, 1535-1541 (2002). pme PHMBA7 0031-9155 10.1088/0031-9155/47/9/308
26. I., Bronshtein, S., Aulova, A., Juzeniene, V., Iani, L. W., Ma, K. M., Smith, Z., Malik, J., Moan, and B., Ehrenberg. " In vitro and in vivo photosensitization by protoporphyrins prossessing different lipophilicities and vertical lacalizaotion in the membrane, ", Photochem. Photobiol., 82, 1319-1325 (2006). pho PHCBAP 0031-8655 10.1562/2006-04-02-RA-865
27. D. J., Robinson, H. S., de Bruijn, N., van der Veen, M. R., Stringer, S. B., Brown, and W. M., Star, " Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect, ", Photochem. Photobiol., 67, 140-149 (1998). pho PHCBAP 0031-8655 10.1111/j.1751-1097.1998.tb05177.x
28. Y. X., Wu and D., Xing, " Permeating efficiency and localization of FCLA and HpD through membrane of lung, cancer cell, ", Acta Laser Biol. Sin., 14 (4), 287-291 (2005).
29. R., Schmidt, " The influence of heavy atoms on the deactivation of singlet oxygen (delta) in solution, ", J. Am. Chem. Soc., 111, 6983-6987 (1989). acs JACSAT 0002-7863 10.1021/ja00200a013
30. H. W., Wang, M. E., Putt, M. J., Emanuele, D. B, Shin, E., Glatstein, A. G., Yodh, and T. M., Busch, " Treatment-induced changes in tumer oxygenation predict photodynamic therapy outcome, ", Cancer Res., 64, 7553-7561 (2004). cnr CNREA8 0008-5472 10.1158/0008-5472.CAN-03-3632
31. M. J., Niedre, C. S., Yu, M. S., Patterson, and B. C., Wilson, " Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid, ", Br. J. Cancer, 92, 298-304 (2005). bjc BJCAAI 0007-0920
32. A., Ferrario, C. F., Chantrain, K. v., Tiehl, S., Buckley, N., Rucker, D. R., Shalinsky, H., Shimada, Y. A., Declerck, and C. J., Gomer, " The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model, ", Cancer Res., 64, 2328-2332 (2004). cnr CNREA8 0008-5472 10.1158/0008-5472.CAN-04-0071
33. S., Mitra and T. H., Foster, " Photochemical oxygen consumption sensitized by a porphyrin phosphorescent probe in two model systems, ", Biophys. J., 78, 2597-2605 (2000). bio BIOJAU 0006-3495
34. Q., Chen, M., Chopp, L., Madigan, M. O., Dereski, and F. W., Hetzel, " Damage threshold of normal rat brain in photodynamic therapy, ", Photochem. Photobiol., 64, 163-167 (1996). pho PHCBAP 0031-8655 10.1111/j.1751-1097.1996.tb02437.x
35. B. W., Pogue, L., Lilge, M. S., Patterson, B. C., Wilson, and T., Hasan, " Absorbed photodynamic dose from pulsed versus continuous wave light examined with tissue-simulating dosimeters, ", Appl. Opt., 36 (28), 7257-7269 (1997). apo APOPAI 0003-6935
36. T. J., Farrell, B. C., Wilson, M. S., Patterson, and M. C., Olivo, " Comparison of the in vivo photodynamic threshold dose for photofrin mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model, ", Photochem. Photobiol., 68, 394-399 (1998). pho PHCBAP 0031-8655 10.1111/j.1751-1097.1998.tb09698.x
37. S. K., Bisland, L., Lilge, A., Lin, R., Rusnov, and B. C., Wilson, " Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors, ", Photochem. Photobiol., 80, 22-30 (2004). pho PHCBAP 0031-8655 10.1562/2004-03-05-RA-100.1
38. A., Bogaards, A., Varma, K., Zhang, D., Zach, L., Lilge, P. J., Muller, and B. C., Wilson, " Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development, ", Photochem. Photobiol. Sci., 4 (5), 438-442 (2005). bk8 PPSHCB 1474-905X 10.1039/b414829k
39. P. S., Thong, F., Watt, M. Q., Ren, P. H., Tan, K. C., Soo, and M., Olivo, " Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT, ", J. Photochem. Photobiol., B, 82 (1), 1-8 (2006). jpw JPPBEG 1011-1344 10.1016/j.jphotobiol. 2005.08.002
40. L., Harrison and K., Blackwell, " Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?, ", Oncologist, 9 (5), 31-40 (2004). d33 OCOLF6 1083-7159